Safety of direct oral anticoagulants for gastrointestinal hemorrhage in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of real-world …
Results: A total of 46 studies were included. Apixaban was associated with a reduced risk of
GIH compared with Dabigatran (HR: 0.67, 95% CI, 0.56 to 0.81, I 2: 53.28%), Rivaroxaban …
GIH compared with Dabigatran (HR: 0.67, 95% CI, 0.56 to 0.81, I 2: 53.28%), Rivaroxaban …
Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis of Real …
PA Barakakis, DG Kokkinidis, W Li… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Goals and background Since the introduction of Direct Oral Anticoagulants (DOACs)," real-
world" studies have investigated their safety profile on gastrointestinal hemorrhage (GIH) …
world" studies have investigated their safety profile on gastrointestinal hemorrhage (GIH) …
Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis of Real …
PA Barakakis, DG Kokkinidis, W Li, S Nagraj… - Journal of Clinical … - journals.lww.com
Results: A total of 46 studies were included. Apixaban was associated with a reduced risk of
GIH compared with Dabigatran (HR: 0.67, 95% CI, 0.56 to 0.81, I 2: 53.28%), Rivaroxaban …
GIH compared with Dabigatran (HR: 0.67, 95% CI, 0.56 to 0.81, I 2: 53.28%), Rivaroxaban …